Technical Analysis for PTIX - Protagenic Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.61 | -7.16% | -0.05 |
PTIX closed down 7.16 percent on Friday, November 1, 2024, on 7 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: Nov 12
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| 20 DMA Support | Bullish | -7.16% | |
| 50 DMA Support | Bullish | -7.16% | |
| MACD Bullish Centerline Cross | Bullish | -7.16% | |
| Inside Day | Range Contraction | -7.16% |
| Alert | Time |
|---|---|
| 50 DMA Resistance | 1 day ago |
| 10 DMA Resistance | 1 day ago |
| Possible NR7 | 1 day ago |
| Possible Inside Day | 1 day ago |
| Down 5% | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunology Mood Disorders Pre Clinical Biopharmaceutical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunology Mood Disorders Pre Clinical Biopharmaceutical
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.87 |
| 52 Week Low | 0.49 |
| Average Volume | 315,853 |
| 200-Day Moving Average | 0.98 |
| 50-Day Moving Average | 0.64 |
| 20-Day Moving Average | 0.60 |
| 10-Day Moving Average | 0.64 |
| Average True Range | 0.09 |
| RSI (14) | 48.72 |
| ADX | 22.6 |
| +DI | 27.34 |
| -DI | 12.90 |
| Chandelier Exit (Long, 3 ATRs) | 0.55 |
| Chandelier Exit (Short, 3 ATRs) | 0.76 |
| Upper Bollinger Bands | 0.70 |
| Lower Bollinger Band | 0.49 |
| Percent B (%b) | 0.55 |
| BandWidth | 35.21 |
| MACD Line | 0.00 |
| MACD Signal Line | -0.01 |
| MACD Histogram | 0.0071 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.68 | ||||
| Resistance 3 (R3) | 0.69 | 0.67 | 0.67 | ||
| Resistance 2 (R2) | 0.67 | 0.65 | 0.67 | 0.67 | |
| Resistance 1 (R1) | 0.64 | 0.64 | 0.63 | 0.63 | 0.66 |
| Pivot Point | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 |
| Support 1 (S1) | 0.59 | 0.60 | 0.58 | 0.58 | 0.56 |
| Support 2 (S2) | 0.57 | 0.59 | 0.57 | 0.55 | |
| Support 3 (S3) | 0.54 | 0.57 | 0.55 | ||
| Support 4 (S4) | 0.53 |
